Login / Signup

Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial.

Keiichi FujiwaraHiroyuki FujiwaraHiroyuki YoshidaToyomi SatohKan YonemoriShoji NagaoTakashi MatsumotoHiroaki KobayashiHughes BourgeoisPhilipp HarterAnna Maria MosconiIsabel Palacio VazquezReinthaller AlexanderTomoko FujitaPhilip RoweEric Pujade-LauraineIsabelle L Ray-Coquard
Published in: Journal of gynecologic oncology (2021)
ClinicalTrials.gov Identifier: NCT02477644.
Keyphrases
  • newly diagnosed
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • metastatic colorectal cancer
  • replacement therapy